Save
Bookmark
Print
Sponsor Name | |
Tumor Site | Small Cell Lung Cancer |
Disease Stage | Stage IV |
Clinical Status | Maintenance Therapy |
Phase | Phase III |
Intervention / Treatment | Rovalpituzumab Teserine |
Research Site | Quebec |
Investigator | Dre Lise Tremblay |
Telephone Number | 418-656-8711 ext 2639 |
Study Start Date | January 26, 2017 |
Study End Date | November 30, 2019 |
Trial Status | Recruitment Complete |